These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 7889265)

  • 1. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
    Filep JG; Fournier A; Földes-Filep E
    Br J Pharmacol; 1994 Jul; 112(3):963-71. PubMed ID: 7921626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors.
    Laszlo F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Apr; 111(4):1309-15. PubMed ID: 7518298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxaemia in rats: role of NO, PAF and TXA2 in pulmonary neutrophil sequestration and hyperlactataemia.
    Olszanecki R; Chłopicki S
    J Physiol Pharmacol; 1999 Sep; 50(3):443-54. PubMed ID: 10574473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation by nitrosothiol NO donors of acute intestinal microvascular dysfunction in the rat.
    László F; Whittle BJ; Moncada S
    Br J Pharmacol; 1995 Jun; 115(3):498-502. PubMed ID: 7582463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide and platelet-activating factor in the initiation of indomethacin-provoked intestinal inflammation in rats.
    László F; Whittle BJ
    Eur J Pharmacol; 1998 Mar; 344(2-3):191-5. PubMed ID: 9600654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
    De Kimpe SJ; Thiemermann C; Vane JR
    Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia.
    Walther A; Yilmaz N; Schmidt W; Bach A; Gebhard MM; Martin E; Schmidt H
    J Surg Res; 2000 Oct; 93(2):265-71. PubMed ID: 11027469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive nitric oxide modulates the injurious actions of vasopressin on rat intestinal microcirculation in acute endotoxaemia.
    László F; Whittle BJ
    Eur J Pharmacol; 1994 Aug; 260(2-3):265-8. PubMed ID: 7988655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous nitric oxide in the maintenance of rat microvascular integrity against widespread plasma leakage following abdominal laparotomy.
    László F; Whittle BJ
    Br J Pharmacol; 1999 Jan; 126(2):515-21. PubMed ID: 10077246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats.
    Bocheński J; Chłopicki S; Gryglewski RJ
    J Physiol Pharmacol; 1999 Jun; 50(2):287-97. PubMed ID: 10424723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of pro-inflammatory and vasoactive mediators with nitric oxide in the regulation of rat vascular permeability during laparotomy.
    Pávó I; Pozsár J; Morschl E; Nemcsik J; László F; Whittle BJ
    Eur J Pharmacol; 2000 Aug; 402(1-2):193-7. PubMed ID: 10940373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure.
    Lopes-Martins R; Catelli M; Araújo C; Estato V; Cordeiro R; Tibiriçá E
    Eur J Pharmacol; 1996 Jul; 308(3):287-94. PubMed ID: 8858301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airways.
    Sirois MG; Plante GE; Braquet P; Sirois P
    Br J Pharmacol; 1990 Dec; 101(4):896-900. PubMed ID: 2085713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin.
    Whittle BJ; László F; Evans SM; Moncada S
    Br J Pharmacol; 1995 Oct; 116(4):2286-90. PubMed ID: 8564261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2.
    Rizzo A; Taylor AE; Townsley MI; Logsdon P; Khimenko PL; Fletcher JR
    Am J Physiol; 1995 May; 268(5 Pt 2):H1954-8. PubMed ID: 7771545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
    Noguchi K; Matsuzaki T; Shiroma N; Ojiri Y; Sakanashi M
    Br J Pharmacol; 1996 Jun; 118(4):941-50. PubMed ID: 8799566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nitric oxide and platelet-activating factor in the inhibition by endotoxin of pentagastrin-stimulated gastric acid secretion.
    Martinez-Cuesta MA; Barrachina MD; Piqué JM; Whittle BJ; Esplugues JV
    Eur J Pharmacol; 1992 Aug; 218(2-3):351-4. PubMed ID: 1385169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of yangambin on cardiovascular hyporeactivity to catecholamines in rats with endotoxin-induced shock.
    Araújo CV; Barbosa-Filho JM; Cordeiro RS; Tibiriçá E
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):267-75. PubMed ID: 11284440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.